OFI Invest Asset Management Has $5.29 Million Stock Position in Axon Enterprise, Inc $AXON

OFI Invest Asset Management trimmed its position in Axon Enterprise, Inc (NASDAQ:AXON) by 99.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,310 shares of the biotechnology company’s stock after selling 2,790,848 shares during the quarter. OFI Invest Asset Management’s holdings in Axon Enterprise were worth $5,287,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Stone House Investment Management LLC acquired a new stake in Axon Enterprise in the third quarter worth about $29,000. New Millennium Group LLC acquired a new stake in Axon Enterprise in the third quarter worth about $29,000. Sound Income Strategies LLC increased its position in Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares during the period. Root Financial Partners LLC acquired a new stake in Axon Enterprise in the third quarter worth about $34,000. Finally, Lodestone Wealth Management LLC acquired a new stake in Axon Enterprise in the fourth quarter worth about $35,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other news, Director Jeri Williams sold 157 shares of Axon Enterprise stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total transaction of $76,930.00. Following the transaction, the director owned 1,159 shares in the company, valued at $567,910. The trade was a 11.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total value of $5,002,400.00. Following the transaction, the chief executive officer owned 3,090,997 shares in the company, valued at $1,546,240,339.28. This trade represents a 0.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,855 shares of company stock worth $7,109,828 over the last three months. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Down 10.3%

NASDAQ:AXON opened at $351.33 on Friday. Axon Enterprise, Inc has a fifty-two week low of $347.28 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29. The stock has a market capitalization of $28.25 billion, a PE ratio of 231.14, a price-to-earnings-growth ratio of 8.36 and a beta of 1.61. The business’s 50-day simple moving average is $467.16 and its 200-day simple moving average is $569.82.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business had revenue of $796.72 million for the quarter, compared to analysts’ expectations of $755.29 million. During the same quarter in the previous year, the business posted $2.08 EPS. Axon Enterprise’s revenue for the quarter was up 38.5% on a year-over-year basis. Sell-side analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on AXON. The Goldman Sachs Group lowered their price objective on Axon Enterprise from $720.00 to $625.00 and set a “buy” rating for the company in a research report on Wednesday. Royal Bank Of Canada reduced their target price on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a report on Wednesday, February 25th. Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. TD Cowen reduced their target price on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Barclays reduced their target price on Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $755.88.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Wall Street reaffirmations and bullish notes tied to Axon Week and new AI products have supported the stock recently; several analysts reiterated buy ratings and highlighted AI-driven growth as a reason to view the pullback as a buying opportunity. Why Axon Stock Bounced Back After Falling 10%
• Positive Sentiment: Axon unveiled new AI offerings (Axon Vision, expanded Axon Assistant, Axon 911) at its annual conference intended to boost real-time public-safety data capabilities — a product roadmap that analysts say could drive multi-year revenue and margin improvement. Can Axon’s New AI Suite Reframe Its Real-Time Data Advantage Story for Investors (AXON)?
• Neutral Sentiment: Analysts trimmed price targets (Goldman Sachs and TD Cowen cut targets) but largely maintained constructive ratings — this reduces upside in the near term while leaving longer-term bull cases intact. Goldman Sachs price target update
• Neutral Sentiment: Sector/market news (e.g., coverage of peers and ad-tech moves) may be pulling investor attention and flows away from defensible growth stories, but these items are indirect for Axon. Macquarie sees AppLovin’s e-commerce push as a multi-year growth driver
• Negative Sentiment: New legal risk headlines tied to the company’s HQ and the cumulative effect of price-target cuts triggered fresh selling pressure; those headlines were cited by market coverage as a primary reason shares moved lower. Why Axon (AXON) Shares Are Trading Lower Today
• Negative Sentiment: Today’s decline was compounded by momentum selling and elevated volume after yesterday’s drop; market commentary and drop reports amplified the move. Axon Enterprise (AXON) Stock Drops Despite Market Gains

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.